Lightwood–Albright syndrome
| Lightwood–Albright syndrome | |
|---|---|
| Synonyms | Renal tubular acidosis type 1, Distal renal tubular acidosis |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Metabolic acidosis, Hypokalemia, Nephrocalcinosis, Bone demineralization |
| Complications | Kidney stones, Chronic kidney disease |
| Onset | Childhood |
| Duration | Chronic |
| Types | N/A |
| Causes | Genetic mutation |
| Risks | Family history |
| Diagnosis | Blood test, Urine test, Genetic testing |
| Differential diagnosis | Proximal renal tubular acidosis, Bartter syndrome, Gitelman syndrome |
| Prevention | N/A |
| Treatment | Alkali therapy, Potassium supplements |
| Medication | Sodium bicarbonate, Potassium citrate |
| Prognosis | Variable, depends on treatment adherence |
| Frequency | Rare |
| Deaths | N/A |
Lightwood–Albright syndrome is a rare genetic disorder characterized by a combination of renal tubular acidosis (RTA) and osteomalacia. This condition is also known as renal tubular acidosis type 2 or proximal renal tubular acidosis.
Presentation[edit]
Individuals with Lightwood–Albright syndrome typically present with symptoms related to the kidneys and bones. The primary features include:
- Renal tubular acidosis: A condition where the kidneys fail to properly acidify the urine, leading to an accumulation of acid in the blood.
- Osteomalacia: Softening of the bones due to defective bone mineralization, often resulting in bone pain and fractures.
Pathophysiology[edit]
The underlying cause of Lightwood–Albright syndrome is a defect in the renal tubules, specifically in the proximal tubules. This defect impairs the reabsorption of bicarbonate, leading to a decrease in blood pH (acidosis). The acidosis, in turn, affects bone metabolism, resulting in osteomalacia.
Diagnosis[edit]
Diagnosis of Lightwood–Albright syndrome involves a combination of clinical evaluation, laboratory tests, and imaging studies. Key diagnostic criteria include:
- Blood tests showing metabolic acidosis with normal anion gap.
- Urine tests indicating impaired bicarbonate reabsorption.
- Bone density scans revealing osteomalacia.
Treatment[edit]
Management of Lightwood–Albright syndrome focuses on correcting the acidosis and addressing bone health. Treatment options include:
- Oral bicarbonate or citrate supplements to neutralize the acid in the blood.
- Vitamin D and calcium supplements to support bone health.
- Monitoring and managing any complications related to the kidneys and bones.
Prognosis[edit]
The prognosis for individuals with Lightwood–Albright syndrome varies depending on the severity of the condition and the effectiveness of treatment. With appropriate management, many patients can lead relatively normal lives, although they may require ongoing medical care.
Related Pages[edit]
Categories[edit]
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian